Search for: "AmerisourceBergen Corporation" Results 41 - 60 of 77
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Sep 2020, 2:06 pm by Kevin LaCroix
Among many other things, investors and activists are raising concerns about the lack of racial diversity on corporate boards. [read post]
6 Sep 2020, 6:04 pm by Francis Pileggi
Background According to the 2019 complaint, that is exactly what happened in 2001 when AmerisourceBergen Corp., a Delaware-chartered pharmaceutical distribution and sourcing company based in Chesterbrook, Pa., acquired Oncology Supply Pharmacy Services and made it part of AmerisourceBergen Specialty Group. [read post]
12 Jul 2020, 6:07 pm by Francis Pileggi
For the last 15 years, I have published a list of key corporate and commercial decisions by the Delaware Supreme Court and Court of Chancery on these pages. [read post]
23 Mar 2020, 4:21 pm by Kandace Watson
(CCH) P94,334 (“[Directors] may find it prudent (and are authorized) to make decisions that are expected to promote corporate (and shareholder) long run interests, even if short run share value can be expected to be negatively affected, and thus directors in pursuit of long run corporate (and shareholder) value may be sensitive to the claims of other ‘corporate constituencies. [read post]
13 Feb 2020, 6:41 am
AmerisourceBergen Corporation, the Delaware Court of Chancery ordered the inspection of the books and records of AmerisourceBergen Corporation, one of the leading opioid distributors in the country, for the purpose of investigating potential mismanagement or breaches of fiduciary duty in connection with the company’s distribution of opioids. [read post]
19 Jan 2020, 8:32 pm by Carl Neff
AmerisourceBergen Corporation, Vice Chancellor Laster ordered  AmerisourceBergen Corporation (“AmerisourceBergen” or the “Company”) to make available for inspection board-level documents formally evidencing the directors’ deliberations and decisions and the materials that the directors formally received and considered (the “Formal Board Materials”) relating to whether AmerisourceBergen… [read post]
18 Nov 2019, 4:24 am by Whittel & Melton, LLC
In recent lawsuits, the defendants have included McKesson Corporation, Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, Covidien, Johnson & Johnson, CVS, Walgreens, and Rite Aid. [read post]
1 Jan 2019, 5:10 pm by Ben Vernia
   https://www.justice.gov/opa/pr/amerisourcebergen-corporation-agrees-pay-625-million-resolve-allegations-it-illegally. [read post]
30 Oct 2018, 4:12 pm by Sabrina I. Pacifici
There 80 towns and cities sued several major drug companies under RICO, including AmerisourceBergen Drug Corporation, Purdue Pharma L.P., and Janssen Pharmaceuticals Inc., among others, seeking damages over the opioid crisis. [read post]
17 Oct 2018, 6:33 am by Ben Vernia
According to DOJ’s press release: The Department of Justice announced today that AmerisourceBergen Corporation and its subsidiaries AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Drug Corporation (ABDC), Oncology Supply Company (OSC), and Medical Initiatives Inc. [read post]
7 Mar 2018, 2:07 pm by William Theisen
The complaint names AmerisourceBergen Drug Corporation, Cardinal Health, and McKesson Corporation [corporate websites], companies that collectively account for about 90 percent of all prescription drug revenue in Chicago and are colloquially known as the "Big Three," as defendants. [read post]
30 Nov 2017, 8:59 pm by Brenda Fulmer
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
19 Dec 2012, 9:47 pm by Ben Vernia
An additional case was resolved by a related settlement: In a separate civil settlement, International Nephrology Network (INN), renamed Integrated Nephrology Network, a subsidiary of AmerisourceBergen Corporation, has also agreed to pay $15 million to resolve civil liability arising from its role in the marketing of Aranesp. [read post]
17 Jul 2012, 2:49 pm by William A. Ruskin
Swartz, Chief Compliance Officer for AmerisourceBergen Corporation in Philadelphia; John Thacher, Director of Managed Review Services at TechLaw Solutions in New York City; Brian T. [read post]